YUVA-GT-F801
/ SZGIMI
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 23, 2019
Lentiviral FVIII Gene Therapy
(clinicaltrials.gov)
- P1; N=10; Not yet recruiting; Sponsor: Shenzhen Geno-Immune Medical Institute; Phase classification: P1/2 ➔ P1
Phase classification
1 to 1
Of
1
Go to page
1